These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 23407783)

  • 1. The CRF₁ receptor antagonist SSR125543 prevents stress-induced cognitive deficit associated with hippocampal dysfunction: comparison with paroxetine and D-cycloserine.
    Philbert J; Belzung C; Griebel G
    Psychopharmacology (Berl); 2013 Jul; 228(1):97-107. PubMed ID: 23407783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The CRF₁ receptor antagonist SSR125543 prevents stress-induced long-lasting sleep disturbances in a mouse model of PTSD: comparison with paroxetine and d-cycloserine.
    Philbert J; Beeské S; Belzung C; Griebel G
    Behav Brain Res; 2015 Feb; 279():41-6. PubMed ID: 25446760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The CRF₁ receptor antagonist SSR125543 attenuates long-term cognitive deficit induced by acute inescapable stress in mice, independently from the hypothalamic pituitary adrenal axis.
    Philbert J; Pichat P; Palme R; Belzung C; Griebel G
    Pharmacol Biochem Behav; 2012 Sep; 102(3):415-22. PubMed ID: 22659580
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The corticotropin-releasing factor 1 receptor antagonist, SSR125543, and the vasopressin 1b receptor antagonist, SSR149415, prevent stress-induced cognitive impairment in mice.
    Urani A; Philbert J; Cohen C; Griebel G
    Pharmacol Biochem Behav; 2011 May; 98(3):425-31. PubMed ID: 21356230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antidepressant-like effects of the corticotropin-releasing factor 1 receptor antagonist, SSR125543, and the vasopressin 1b receptor antagonist, SSR149415, in a DRL-72 s schedule in the rat.
    Louis C; Cohen C; Depoortère R; Griebel G
    Neuropsychopharmacology; 2006 Oct; 31(10):2180-7. PubMed ID: 16452986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of the vasopressin (V1b) receptor antagonist, SSR149415, and the corticotropin-releasing factor 1 receptor antagonist, SSR125543, on FG 7142-induced increase in acetylcholine and norepinephrine release in the rat.
    Claustre Y; Rouquier L; Desvignes C; Leonetti M; Montégut J; Aubin N; Allouard N; Bougault I; Oury-Donat F; Steinberg R
    Neuroscience; 2006 Sep; 141(3):1481-8. PubMed ID: 16781820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deep brain stimulation in treatment-resistant depression in mice: comparison with the CRF1 antagonist, SSR125543.
    Dournes C; Beeské S; Belzung C; Griebel G
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Jan; 40():213-20. PubMed ID: 23367508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of the CRF1 receptor antagonist SSR125543 on energy balance and food deprivation-induced neuronal activation in obese Zucker rats.
    Doyon C; Samson P; Lalonde J; Richard D
    J Endocrinol; 2007 Apr; 193(1):11-9. PubMed ID: 17400798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antidepressant-like effects of CRF1 receptor antagonist SSR125543 in an animal model of depression.
    Overstreet DH; Griebel G
    Eur J Pharmacol; 2004 Aug; 497(1):49-53. PubMed ID: 15321734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of a stressor and corticotrophin releasing factor on ethanol deprivation-induced ethanol intake and anxiety-like behavior in alcohol-preferring P rats.
    Knapp DJ; Overstreet DH; Huang M; Wills TA; Whitman BA; Angel RA; Sinnett SE; Breese GR
    Psychopharmacology (Berl); 2011 Nov; 218(1):179-89. PubMed ID: 21643675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CRF1 receptor antagonists do not reverse pharmacological disruption of prepulse inhibition in rodents.
    Douma TN; Millan MJ; Boulay D; Griebel G; Verdouw PM; Westphal KG; Olivier B; Groenink L
    Psychopharmacology (Berl); 2014 Apr; 231(7):1289-303. PubMed ID: 24186076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug-dependent requirement of hippocampal neurogenesis in a model of depression and of antidepressant reversal.
    Surget A; Saxe M; Leman S; Ibarguen-Vargas Y; Chalon S; Griebel G; Hen R; Belzung C
    Biol Psychiatry; 2008 Aug; 64(4):293-301. PubMed ID: 18406399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early adolescent stress-induced changes in prefrontal cortex miRNA-135a and hippocampal miRNA-16 in male rats.
    Liu Y; Liu D; Xu J; Jiang H; Pan F
    Dev Psychobiol; 2017 Dec; 59(8):958-969. PubMed ID: 28944448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of single prolonged stress and D-cycloserine on contextual fear extinction and hippocampal NMDA receptor expression in a rat model of PTSD.
    Yamamoto S; Morinobu S; Fuchikami M; Kurata A; Kozuru T; Yamawaki S
    Neuropsychopharmacology; 2008 Aug; 33(9):2108-16. PubMed ID: 17957211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Control of Stress-Induced ACTH Secretion by Vasopressin and CRH: Additional Evidence.
    Ramos AT; Tufik S; Troncone LR
    Neuropsychobiology; 2016; 73(3):184-90. PubMed ID: 27221315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SSRI or CRF antagonism partially ameliorate depressive-like behavior after adolescent social defeat.
    Bourke CH; Glasper ER; Neigh GN
    Behav Brain Res; 2014 Aug; 270():295-9. PubMed ID: 24867331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-selective orexin-receptor antagonist attenuates stress-re-stress-induced core PTSD-like symptoms in rats: Behavioural and neurochemical analyses.
    Prajapati SK; Krishnamurthy S
    Behav Brain Res; 2021 Feb; 399():113015. PubMed ID: 33212086
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytokine involvement in stress may depend on corticotrophin releasing factor to sensitize ethanol withdrawal anxiety.
    Knapp DJ; Whitman BA; Wills TA; Angel RA; Overstreet DH; Criswell HE; Ming Z; Breese GR
    Brain Behav Immun; 2011 Jun; 25 Suppl 1(Suppl 1):S146-54. PubMed ID: 21377524
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CRF
    Verdouw PM; van Esterik JC; Peeters BW; Millan MJ; Groenink L
    Pharmacol Biochem Behav; 2017 Mar; 154():11-19. PubMed ID: 28089628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blockade of corticotropin-releasing hormone receptor 1 attenuates early-life stress-induced synaptic abnormalities in the neonatal hippocampus.
    Liao XM; Yang XD; Jia J; Li JT; Xie XM; Su YA; Schmidt MV; Si TM; Wang XD
    Hippocampus; 2014 May; 24(5):528-40. PubMed ID: 24493406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.